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Structural Basis for the Restoration of TCR Recognition
of an MHC Allelic Variant by Peptide Secondary
Anchor Substitution
Michael J. Miley,1 Ilhem Messaoudi,3,4 Beatrix M. Metzner,3,4 Yudong Wu,1
Janko Nikolich- Ž ugich,3,4 and Daved H. Fremont1,2
of Pathology and Immunology and 2Department of Biochemistry and Molecular Biophysics,
Washington University School of Medicine, St. Louis, MO 63110
3Vaccine and Gene Therapy Institute and 4Oregon National Primate Research Center, Oregon Health
and Science University, Beaverton, OR 97006

Abstract
Major histocompatibility complex (MHC) class I variants H-2Kb and H-2Kbm8 differ primarily
in the B pocket of the peptide-binding groove, which serves to sequester the P2 secondary anchor
residue. This polymorphism determines resistance to lethal herpes simplex virus (HSV-1) infection
by modulating T cell responses to the immunodominant glycoprotein B498-505 epitope, HSV8.
We studied the molecular basis of these effects and confirmed that T cell receptors raised
against Kb–HSV8 cannot recognize H-2Kbm8–HSV8. However, substitution of SerP2 to GluP2
(peptide H2E) reversed T cell receptor (TCR) recognition; H-2Kbm8–H2E was recognized
whereas H-2Kb–H2E was not. Insight into the structural basis of this discrimination was obtained by determining the crystal structures of all four MHC class I molecules in complex with
bound peptide (pMHCs). Surprisingly, we find no concerted pMHC surface differences that
can explain the differential TCR recognition. However, a correlation is apparent between the
recognition data and the underlying peptide-binding groove chemistry of the B pocket, revealing that secondary anchor residues can profoundly affect TCR engagement through mechanisms distinct from the alteration of the resting state conformation of the pMHC surface.
Key words: major histocompatibility complex • crystallography • antigen presentation •
herpes simplex virus 1 • T cells

Introduction
Cytotoxic CD8 T cells are the main effector arm of the
adaptive immune system in charge of combating intracellular
pathogens. These cells recognize pathogen-derived peptides
presented by surface-expressed MHC class I molecules and
lyse the infected cell that bears them. Analysis of the threedimensional crystal structures of MHC class I molecules in
complex with bound peptide (pMHCs) has revealed in
great molecular detail the mechanisms these proteins use to
bind a vast number of chemically distinct peptides (1, 2).
The peptide-binding groove formed by the 1/2 domains is
structured to bind peptides 8–10 amino acids long in an
extended conformation. Eight -strands establish the platform floor of the groove, with two antiparallel -helices
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serving as its walls. The peptide binds between these helices
and uses its main chain and terminal atoms to form extensive hydrogen bonds to MHC side chains, enabling peptide
binding in a predominantly sequence-independent manner.
Peptide selectivity is achieved via discrete peptide-binding
pockets present in the groove that are tailored to preferentially accept a subset of peptide side chains dubbed binding
anchors. The high degree of polymorphism observed in
class I alleles is clustered to residues that form these binding
pockets, providing the basis for allele-specific peptide-binding motifs (3). The motifs for most MHC class I alleles can
be described as a combination of preferred residues located at primary and secondary anchor positions (4). Primary
anchor residues are typically completely buried within the
peptide-binding groove pockets in a tightly coordinated
Abbreviations used in this paper: ASU, asymmetric unit; CD, circular dichroism; pMHC, MHC class I molecule in complex with bound peptide; SC,
shape complementarity; Tm, midpoint of thermal denaturation.
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(20). We have previously characterized an important secondary anchor located at the peptide P2 position that lies
sequestered in the B pocket of the Kb groove that, in this
allele, is directly adjacent to the C pocket (21). Interestingly, the preferred residue at P2 depends on which primary anchor occupies the C pocket; Ala and Gly are
preferred if the C pocket anchor is Tyr, whereas mediumsized residues predominate for primary Phe anchors (15,
21). Peptide elution experiments demonstrated that many
peptides ignore the Kbm8 mutation and are able to bind to
both molecules with high stability, although a subset does
bind differentially (20, 22). Despite the discrete nature of
the change in Kbm8, the two molecules exhibit differences
in several interrelated biological properties, including peptide-dependent antibody recognition (23), cross-reactivity
(24, 25), peptide binding and presentation (11, 14, 25, 26),
and intrathymic repertoire selection (27, 28). Most importantly, the coisogeneic mouse strains C57BL/6 (B6, H-2b)
and B6.C-H-2bm8 (bm8, H-2bm8), which differ from each
other solely by expression of Kb or Kbm8, also differ in susceptibility to HSV-1, due to the fact that the dominant
epitope of this virus, the glycoprotein B epitope 498-505
(called here HSV8), elicits a markedly more efficient CTL
response in bm8 mice (29).
Previously, we reported that B6 mice immunized with
HSV8 produce CTLs, which readily recognize Kb–HSV8,
but are unable to recognize Kbm8–HSV8 (14). This difference was not due to differential affinity or stability of
peptide binding, nor was it due to gross conformational
changes, as assayed by a panel of conformation-sensitive
antibodies. As the alteration in Kbm8 potentially changes the
hydrogen bond network between the peptide P2 side chain
and the MHC B pocket, we hypothesized that this change
might somehow be manifest at the pMHC surface, where it
could be directly detected by TCR. To test this hypothesis,
we performed second-site reversion of the Kbm8 mutation
by introducing compensatory P2 peptide mutations that
could restore the lost hydrogen bond network. Indeed,
changing the peptide SerP2 to a GluP2 (H2E peptide) compensated for the reciprocal Glu24 to Ser24 mutation present
in Kbm8, so that the same Kb–HSV8-reactive TCR that
could not recognize Kbm8–HSV8 was able to recognize
Kbm8–H2E. However, when this H2E peptide was bound
to Kb, there was no detectable TCR recognition. Although
our paper highlighted an important role for secondary anchor residues in TCR recognition, it remained unclear how
exactly these B pocket interactions were being discerned.
To resolve this issue at the atomic level, we have now
undertaken the study of these pMHCs by protein crystallography, solving the crystal structures of four distinct complexes: Kb–HSV8, Kbm8–HSV8, Kb–H2E, and Kbm8–H2E.
Examining the surface properties of each pMHC revealed,
to our surprise, only nonconcerted differences that do not
appear to correlate with T cell activation profiles. However, our structures did reveal localized features of the
pMHC B pockets that do correspond with our TCR recognition data. When compared with Kb–HSV8, Kbm8–
HSV8 and Kb–H2E contained alternate hydrogen bonding
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fashion; only a highly restricted set of amino acids can typically serve as the primary anchor of a given pocket, allowing for highly stable peptide binding. In contrast, secondary
anchor residues tend to be less restrictive in allowable sequence due to flexibility of the engaging pocket, and their
substitution to less favorable residues often does not markedly affect peptide-binding affinity or kinetics.
TCR recognition of pMHC has also been studied extensively (5). The recent crystal structures of TCR–pMHC
complexes have demonstrated that the TCR binds in a
roughly diagonal orientation over the groove-flanking
-helices, positioning its CDR loops over the peptide (6–8).
Numerous studies examining the role of solvent-exposed,
TCR-contacting peptide side chains in TCR recognition
have shown that even minor chemical differences in them
can be discerned (9–12). In contrast, the peptide anchor side
chains are buried and are thought unable to directly contact
the TCR. These, and other similar observations, suggest that
modulation of peptide-binding affinity is the dominant way
anchor side chains affect TCR recognition. However, our
group and others have recently reexamined this issue and
have shown that peptide anchor side chains, especially secondary anchors, can have a more direct effect, independent
of peptide-binding affinity, on TCR recognition (13–15).
One of the best-studied models in which discrete variation affects one of the minor anchor pockets of an MHC
class I molecule is provided by allelic variant molecules
H-2Kb (Kb) and its spontaneous mutant, H-2Kbm8 (Kbm8).
Kbm8 arose from Kb by a gene conversion event (16) that
changed four amino acids [Tyr22 to Phe22; Met23 to Ile23;
Glu24 to Ser24; and Asp30 to Asn30] all located on the platform floor of the peptide-binding groove. Of these four
residues, two (MHC 23 and 30) are thought to be largely
irrelevant to antigen processing and presentation, as their
side chains point away from the peptide-binding groove,
are not solvent accessible, and are not analogous to residues
shown previously to contact TCRs (17). The two remaining residues, MHC 22 and 24, point into the groove and
serve to create the B pocket, where they contact the side
chain of the second amino acid of the bound peptide (P2).
Indeed, site-directed mutagenesis has shown that most, if
not all, of the effects of the Kbm8 mutation upon presentation of the antigenic peptide OVA-8 can be recapitulated
by isolated mutations at MHC 22 and 24 (18). Notably, Kb
and Kbm8 have identical sequences at their membrane distal
TCR-contacting residues. Therefore, the bulk of biological
differences between them are likely a consequence of indirect effects of the changes in the B pocket, which could be
manifest as differences in peptide-binding preferences or alternate conformations of identically presented peptides.
The hallmark of peptides naturally presented by Kb is the
presence of two primary anchors: a phenylalanine or tyrosine as the fifth (or sixth) residue and a leucine as the last of
eight (or nine) residues (4, 19). These two primary anchors
find themselves deeply buried in the C and F pockets of the
Kb peptide-binding groove, respectively, and their substitution to other amino acids typically results in a dramatic reduction in affinity and pMHC stability at the cell surface
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and chemical environments in their B pockets, resulting in
loss of B6-derived TCR recognition. Alternatively, Kbm8 in
complex with the H2E peptide containing the secondary
anchor substitution resulted in a B pocket environment
closely approximating the one present in Kb–HSV8. Thus,
our results indicate that pMHC binding pocket modifications can profoundly affect TCR activation without significantly altering the resting state (TCR unliganded) conformation of the pMHC surface, demonstrating that they can
be significant determinants in an immune response.

Materials and Methods
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Results
pMHC Crystal Structure Determinations. We reported
previously that B6-derived T cells exhibit a restricted,
mono-specific pattern of recognition of the dominant peptide epitope of the HSV-1, HSV8; this peptide was recognized only when presented by Kb, but not when bound to
its variant, Kbm8 (14). At that time, we hypothesized that
this was due to the loss of hydrogen bonds between SerP2
of HSV8 and the altered B pocket of Kbm8 (particularly due
to the key mutations Tyr22 to Phe22 and Glu24 to Ser24).
We supported this hypothesis by performing second-site
reversion of TCR recognition: introduction of a glutamic
acid at position P2 of HSV8 (peptide H2E) led to reconstitution of T cell recognition of the new pMHC, Kbm8–
H2E. Since then, we have confirmed these observations
using several CTL lines and clones (41).
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Protein Expression and Purification. The Kb ectodomain (1–274)
and m2m were expressed and purified from cell supernatants of
Drosophila melanogaster S2 cells using established protocols (17,
19). In brief, purification consisted of Ni 2 chelation chromatography followed by incubation with molar excess of either HSV8
or H2E peptides. Each peptide was synthesized using standard
protocols and tested for identity by electrospray MS. The resulting complexes were subjected to ion-exchange chromatography
(MonoQ) followed by size exclusion chromatography. Native gel
electrophoresis and isoelectric focusing were used to ensure the
homogeneous nature of these pMHC samples. Additionally, previously published protocols (30) for bacterial expression and subsequent oxidative refolding was used to produce K b (1–274) and
Kbm8 (1–280) ectodomains in complex with m 2m.
Circular Dichroism (CD) and Thermal Denaturation. Experiments were performed in a manner similar to what has been published previously for other MHC class I peptide complexes (31,
32). All four bacterially expressed, oxidatively refolded pMHCs
were buffer exchanged to 0.2 mg/ml (5 m) in 10 mM
KH2PO4/K2HPO4 pH 7.5, 150 mM NaCl, and 0.01% sodium
azide using Centricon filtration devices (Amicon, Inc.). Three independent thermal denaturation experiments per pMHC were
undertaken at the CD shared equipment facility at the University
of Medicine and Dentistry of New Jersey. The midpoint of thermal denaturation (Tm) for each protein was calculated by taking
the first derivative of the ellipticity data at 218 nm and identifying
the inflexion point.
Crystallization and Structure Determinations. Purified Kbm8 and
Kb peptide complexes were concentrated to 5–6 mg/ml in 20 mM
ammonium acetate, pH 6.9, and 0.01% sodium azide. Crystals of
insect cell–expressed Kb peptide complexes were produced in
hanging drops by vapor diffusion at 20 C against wells filled with
3–5% MPD, 2.0 M Na/K2PO4, pH 6.5, and molar excess HSV8
or H2E peptide. Bacterially expressed, oxidatively refolded K bm8
peptide complex crystals were grown similarly in 12–15% PEG
8000, 100 mM sodium cacodylate, pH 6.6, and 100–150 mM calcium acetate. Diffraction quality crystals appeared within 48 h and
were cryoprotected just before flash cooling through the 1:1 addition of well solution plus 20% ethylene glycol (K bm8) or 25% glycerol (Kb). Diffraction data for Kbm8–H2E crystals were collected
using a Rigaku X-ray source and an R-axis IV image plate detector, while data for the other three pMHCs were obtained at the
Advanced Photon Source (APS), beamline ID-19 (SBC-CAT).
Data were indexed and processed using DENZO and SCALEPACK (see Table I and reference 33). Kb peptide complexes
crystallized in the P21212 space group with one pMHC in the
asymmetric unit (ASU), whereas K bm8 peptide complexes crystallized in the P21 space group and had two pMHCs in the ASU. A
nearly isomorphous Kb structure, PDB ID code 1KJ3, without its

peptide and with its mutant residues truncated to alanine, was
rigid body refined into Kbm8–HSV8 data. The HSV8 peptide was
traced and the model was built to high confidence after several iterative rounds of model building in O (34) coupled to atomic refinement and map generation with the CNS program (35). This
high confidence Kbm8–HSV8 model was used as a starting point
for the Kbm8–H2E model. A similar procedure was performed for
the Kb peptide complex structures, with PDB ID code 2VAA
used as the starting point. Each K b–peptide complex model contained m2m (residues 1–99), Kb (residues 1–274), and the respective full-length peptide. The K b–HSV8 complex model contains
one N-linked carbohydrate at Asn 86, whereas the Kb–H2E complex model contains two N-linked carbohydrates at Asn 86 and
Asn176. The m2m present in the Kbm8–peptide complexes contained an additional NH2-terminal Met residue numbered residue
zero. Kbm8 models contained residues 1–278; poor electron density
for Ser279 and Thr280 prevented them from being modeled.
Computational Analysis. Graphical structure representations
were created using Ribbons (36). The molecular surfaces of the B
pockets were generated using sph-ms, a component program of
Ribbons, using a 1.4 Å probe. Specifically, the P2 peptide C
and side chain atoms were removed from the structure, and
sph-ms was used to generate the dot surface of the B pocket with
the rest of the peptide bound. The geometric surface complementarity of the peptide–MHC interfaces was calculated with the
program SC (37). Electrostatic potential maps were generated with
Delphi, and Grasp was used to read in these maps and graphically
display each pMHC’s electrostatic molecular surface potential
(38). The 2C TCR from the Kb–2C complex (PDB idcode 2CKB)
was docked via the MHC 1/2 regions onto our pMHCs.
PDBDIST was used to determine TCR–pMHC contacts within
4.2 Å and these delineated the TCR contact box present in Fig. 2
(39). HBplus was used to determine the hydrogen bonding in
each pMHC’s B pocket (40). RMSD calculations between structures were calculated with the CNS program using pMHCs superimposed via their 1/2 domains (35). RMSDs of mutant
residues were calculated using positionally equivalent atoms (i.e.,
side chain O of SerP2 considered equivalent to Glu P2 side chain
C). The reference structure for these calculations was one of the
Kbm8–H2E structures (chains D and Q) in the ASU. Simulated
annealing electron density omit maps of B pocket residues for
each complex were generated using the CNS program and displayed in Ribbons (35, 36).
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Figure 1. Crystallographic electron density maps of the pMHC B
pockets. Sigma-weighted simulated annealing Fo-Fc omit electron density
maps contoured at 3.5 around the B pocket regions of all four pMHCs.
(cyan) Kb and Kbm8 carbon; (yellow) HSV8 and H2E peptide carbon;
(red) oxygen; (blue) nitrogen; (orange) water. Recognized pMHCs are in
green boxes and unrecognized pMHCs are in red boxes.
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chains of SerP1, GluP4, AlaP6, and ArgP7. Although the SerP1
side chain is solvent inaccessible due to its small size, the
other three side chains have significant solvent exposure.
These observations are consistent with studies that demonstrate P4, P6, and P7 residues of HSV8 are major TCR determinants, with larger substitutions at P1 also perturbing
TCR recognition (11, 14, 23).
Comparison of pMHC Surface Properties. It has been
shown previously that small but significant differences in
pMHC surface properties can occur between peptides presented by Kb and its natural occurring variants (17). SEV9
and VSV8 peptides in complex with Kbm1 have a notably
different electrostatic surface compared with analogous Kb
complexes, whereas the Kbm8 complexes were very similar
to those of Kb. We initiated a structural analysis of our
pMHCs to determine if any significant differences could be
identified. The electrostatic surface properties of each
pMHC were calculated using Delphi and visualized using
GRASP. This analysis reveals the potential TCR interacting surface of each pMHC to be virtually indistinguishable
from one another, with the exception of the surface surrounding the ArgP7 peptide residue (Fig. 2). The significance of this difference is likely minimal as it is due to alternate crystal contacts that, in Kb, are positioned over the
COOH terminus of the peptide. This results in a different
conformation of the ArgP7 side chain as well as a small local
rearrangement that is centered around Ser73. It is unlikely
that this rearrangement plays a significant role in TCR recognition, as the conformation of ArgP7 is nearly isostructural
between respective recognized and unrecognized pMHC
structures (i.e., Kbm8–H2E vs. Kbm8–HSV8).

Figure 2. pMHC electrostatic surface properties. The membrane-distal,
peptide-binding platforms of all four pMHCs are depicted. Electrostatic
properties were mapped to the molecular surfaces using the program
GRASP. Surface colors are contoured from red (8kT) to blue (8kT).
Elements of the surface corresponding to the peptides are approximately
enclosed with dashed lines. (solid lines) The portion of the pMHC surface
containing modeled 2C TCR contacts is boxed.

TCR Discrimination of B Pocket Variation in pMHCs
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In this paper, we set out to solve the crystal structures of
all four pMHCs to ascertain whether any differences exist
that could explain our differential TCR recognition. Kb–
HSV8 and Kb–H2E were expressed in D. melanogaster cells
and recovered from cell supernatants, whereas Kbm8–HSV8
and Kbm8–H2E were oxidatively refolded from Escherichia
coli inclusion bodies. The Kb–peptide complexes crystallized in the primitive orthorhombic space group P21212
with one pMHC in the ASU. The Kbm8–peptide complexes, which lack N-linked carbohydrate additions at residues Asn86 and Asn176, crystallized in the primitive monoclinic space group P21 and have two pMHCs per ASU.
Each structure was solved by molecular replacement and
after several rounds of model building and refinement,
quality atomic models were obtained (Fig. 1). Kb–HSV8
was solved to 2.6 Å resolution, whereas the Kb–H2E complex was solved to 2.1 Å resolution. The estimated coordinate error (Luzzati) for each complex is 0.30 and 0.25 Å,
respectively. Similarly, Kbm8–HSV8 was solved to 1.9 Å
resolution and Kbm8–H2E was solved to 2.6 Å resolution
with estimated coordinate errors of 0.27 and 0.37 Å, respectively. A summary of the data collection and refinement results are presented in Table I.
The structures of Kb and Kbm8 that we have resolved are
very similar to those that have been described previously
(17, 19). The HSV8 and H2E peptides bind in a canonical
fashion to both MHC molecules. The side chains of residues PheP5 and LeuP8 are deeply buried into the MHC
binding groove, serving as primary anchors and sequestering into the C and F pockets, respectively. Similarly, the
Ser/GluP2 and IleP3 side chains are also buried, acting as
secondary anchors at the B and D pockets, respectively.
Pointed away from the peptide-binding groove are the side
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Table I. Summary of Data Collection, Phasing, and Refinement
Data collection for H-2Kb and H2-Kbm8 peptide complexes
Data set
Kbm8–H2E
Space group
Unit cell (abc, Å; , )

Kbm8–HSV8

P21
a = 66.57; b = 90.18;
c = 88.98;  = 111.32;
, = 90

Wavelength (Å)
X-ray source
Resolution, outer shell (Å)
Observations/unique
Completeness (%)
Rsym (%)
I/

Structural analysis
1/2/peptide RMSD (Å)
Peptide SC

P21212
a = 135.24; b = 89.54;
a = 134.89; b = 90.22;
c = 45.25; ,, = 90
c = 45.45; ,, = 90

1.5418

1.0332

Rigaku
20-2.6 (2.7-2.6)
70,233/29,043
95.6 (93.5)
10.2 (42.1)
8.8 (1.8)

APS-19-ID
20-1.9 (1.97-1.9)
411,580/72,537
94.0 (77.7)
7.6 (36.0)
19.9 (3.1)

APS-19-ID
20-2.1 (2.17-2.1)
229,268/32,839
99.9 (100)
7.0 (35.4)
27.3 (5.2)

APS-19-ID
20-2.6 (2.69-2.6)
79,892/17,348
99.1 (99.9)
9.1 (36.9)
15.0 (3.9)

2
23.0 (38.9)
28.7 (43.1)
36.0

2
22.9 (33.5)
25.7 (35.4)
35.0

1
20.7 (24.2)
23.1 (27.1)
32.8

1
19.8 (26.5)
23.9 (35.1)
35.0

0.007/1.33

0.005/1.29

0.005/1.30

0.006/1.30

0.37/0.49

0.27/0.31

0.25/0.16

0.30/0.23

85.4/13.7/1.0
1RJZ

91.7/7.7/0.6
1RJY

89.1/10.3/0.6
1RK1

90.9/8.5/0.6
1RK0

–/0.72
0.71/0.68

0.75/0.92
0.71/0.72

1.23
0.72

1.20
0.70

Next, we undertook a comparative analysis of the pMHC
structures to ascertain whether there is any correlative structure variation. Analysis of 1/2 domain similarity revealed
an RMSD deviation of 0.8 Å between the four Kbm8 1/
2 domains, whereas RMSD deviation between the two Kb
1/2 domains was 0.45 Å. However, the RMSD deviation
between the Kb structures and Kbm8–H2E complex was 1.2 Å
(Table I). These differences in global 1/2 structure can be
largely attributed to differences in loop conformations and, in
the case of Kb to Kbm8 comparisons, differences in crystal
packing and solvent conditions. Specifically, loops between 
strands 1/2, 3/4, and 5/6 were highly divergent, even between both molecules in the ASU of the Kbm8 structures.
Differential crystal packing at the -strand 4/helix 1 region
(MHC 52–57) in the Kbm8 structures results in another area of
significant conformational difference. These regions are not
known to have any influence on conventional TCR recognition. Further inspection of MHC residues did not reveal
other residues with significant, correlated deviations that
could potentially make direct contact with the TCR.
1449
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0.97945

Comparison of the four peptides from these pMHCs
demonstrates that small, but significant, positional differences occur at the amino terminal ends of the peptides.
When the peptides are superimposed, via the respective
MHC 1/2 domains, these differences become clear (Fig.
3). Remarkably, the largest of these structural differences
occurs between the two complexes, Kb–HSV8 and Kbm8–
H2E (Fig. 3, green), which are recognized equivalently.
Seen from a top-down perspective, the most noticeable deviations occur at the P1 and P2 positions, highlighting a lateral displacement of these residues (Fig. 3 A). In contrast,
the two unrecognized complexes, Kb–H2E and Kbm8–
HSV8 (Fig. 3, red), are fairly similar in conformation to the
Kbm8–H2E peptide structure. A side view perspective reveals an additional downward shift of the SerP2 in Kb–HSV8
from the GluP2 of Kbm8–H2E (Fig. 3 B). This displacement
is propagated through the peptide main chain, causing a diminishing shift through P3 and a prominent movement of
P1. The P3–P8 residues, common to all peptides, are nearly
isostructural between Kb and Kbm8 structures, with the ex-
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Refinement statistics
Molecules in ASU
Rcrystal, outer shell (%)
Rfree, outer shell (%)
Avg. temperature factor (Å2)
Rms deviations
Bonds (Å), angles ()
Coordinate error estimates
Luzzati, SigmaA
Ramachandran plot
Favored, allow., gener. (%)
PDB ID code

a = 66.56; b = 90.13;
c = 89.01;  = 111.39;
, = 90

Kb–H2E
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ception of the P7 side chain conformer difference, which is
due to differential crystal packing between Kb and Kbm8.
When these positional deviations were quantitated, we
found that only the peptide amino terminal variations of
Kb–HSV8 and Kbm8–H2E (Fig. 3 C, green bars) were significant, albeit small. Their displacements were two to three
times larger than those observed between Kbm8–H2E and its
replicate in the ASU (Fig. 3 C, black bars), a measure of experimental error. However, these results are in stark contrast
with the TCR recognition data, as the magnitude of the
positional deviation does not correlate to recognition. Together, it is clear that TCR recognition in this system does
not correlate to evident surface properties of the pMHCs,
indicating that the TCR may well be discriminating between other biophysical properties of the complexes.
Comparison of Kb and Kbm8 B Pocket Environments. Kb
and Kbm8 differ in two residues, MHC 22 and MHC 24,
which serve to create B pockets that are unique to each
molecule. A comparison of the B pockets from each of our
pMHCs demonstrates that the bm8 mutations increase the
size and alter the chemical environment, allowing for different peptide-binding modes (Fig. 4). The B pockets in
the Kb–peptide complexes are elongated, but shallow, due
mainly to residue Glu24 that sits directly underneath the P2
anchor (Fig. 5). The Kb B pocket accommodates HSV8
1450

very well, with the SerP2 directly interacting with Glu24. In
contrast, the GluP2 mutation in the H2E peptide is forced
into an unfavorable chemical environment. This GluP2 side
chain is too large to occupy the space where Wat2 is located in the Kb–HSV8 structure; its accommodation would
require rearrangement of several Kb B pocket side chains.
Additionally, that conformation would put the negatively
charged GluP2 in very close proximity to the negatively
charged Glu24 side chain, creating an unfavorable electrostatic interaction given that peptide loading occurs at near
neutral pH. Instead, the GluP2 side chain turns away from
Glu24 and tucks itself underneath the main chain of the
peptide. Surprisingly, the H2E peptide provides a similar
“fit” for the Kb binding groove as the HSV8 peptide, as assessed by comparable shape complementarity (SC) coefficients (Table I and reference 37).
The B pockets of the Kbm8–peptide complexes are significantly altered compared with their Kb counterparts; the bm8
mutations allow the pocket to become much deeper and
more neutral. A secondary effect of these mutations is the
rearrangement of the Tyr45 side chain, causing a widening
and further deepening of the pocket. This rearrangement is
similar to the ones observed in other Kbm8 peptide structures
(17). Accommodation of SerP2 by Kbm8 is very similar to
what is observed in the Kb–HSV8 complex. However, the

TCR Discrimination of B Pocket Variation in pMHCs

Downloaded from jem.rupress.org on September 13, 2011

Figure 3. Positional deviation analysis of MHC presented
peptides. Peptides from all four pMHCs have been superimposed via their 1/2 domains. They are shown from a topdown perspective (A) and a side view (B). (green) Peptides
from recognized pMHCs. (red) Peptides from unrecognized
pMHCs. The large difference observed for ArgP7 is due to alternate crystal packing arising from different space groups. (C) The
positional differences of the peptides were quantitated and
graphed to denote per residue main and side chain differences
in reference to Kbm8–H2E. Recognized peptides (green) and
unrecognized peptides (red) have been compared with one of
the peptides from the Kbm8–H2E crystal structure (chain Q of
1RJZ), with the differences between the two peptides in the
Kbm8–H2E ASU (black) representing a measure of experimental error.
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SerP2 rides higher in the Kbm8 B pocket than in the Kb B
pocket (Fig. 4). This results in a shifting of Wat2 to allow for
favorable interactions between SerP2 and pocket residues,
and for the inclusion of an additional water, Wat4, behind it.
In contrast with the Kb–H2E complex, the larger, and no
longer negatively charged Kbm8 B pocket allows the GluP2
side chain to extend in an alternate conformation similar to
the SerP2 side chains in the other complexes (Fig. 4). This
extension displaces Wat2 and allows the GluP2 side chain to
directly interact with Tyr45. Despite the differences in the
peptide-binding grooves of Kb and Kbm8, and the B pocket
in particular, the fit of both peptides is quantitatively similar,
with SC coefficients ranging from 0.68 to 0.72 (Table I).
Comparison of pMHC Thermostability. The rearrangements we have observed for the peptide P2 and MHC B
pocket residues could potentially alter the stability of the
respective pMHC and, thus, may explain our differential
TCR recognition. Indeed, the sevenfold difference in thermostability observed for SEV9 and VSV8 peptides presented
by Kb and Kbm1 has been implicated in their differential
TCR recognition profiles (17). To address this issue, we
measured the thermostability of each pMHC using CD. All
pMHCs had Tm values 37C, further supporting the observation that they are all stable under physiological conditions (Fig. 6). Reproducibly higher Tm values were observed
for HSV8 complexes (49C) when compared with those
of the H2E complexes (44C). Thus, the thermal stability
of Kb and Kbm8 is dependent on which peptide is loaded, and
the measured stability is in no way correlated with T cell
recognition. Consistent with our CD experiments are previously reported data concerning the cell surface stability of
our pMHCs on living cells as measured by conformationsensitive antibodies (11, 14) and T cell–based assays (29).
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Figure 5. pMHC B pocket hydrogen bonding schemes. The B pocket
hydrogen bonding networks of all four pMHCs are depicted. The specific
interactions of peptide P2 residues with MHC are highlighted. Recognized pMHCs are in green boxes and the unrecognized pMHCs are in
red boxes. (cyan) MHC carbon atoms; (yellow) peptide carbon; (red) oxygen; (blue) nitrogen; (orange) water. Potential hydrogen bonds are depicted
as small purple spheres.

Comparison of B Pocket Hydrogen-bonding Networks. The
diversity of our pMHCs and their TCR recognition does
not seem to correlate with their apparent resting state surface properties, as resolved crystallographically, or with their
relative cell surface and in vitro stabilities. However, this is
not the case when the B pocket environment is examined.
Analysis of B pocket hydrogen-bonding networks and
chemical environments for the four pMHCs reveals an ap-

Figure 6. pMHC thermostability as measured by CD. CD ellipticity
data at 218 nm corresponding to the first melting transition was normalized to a scale of 0 to 1. The Tm for each pMHC is noted in the legend.
All pMHCs experienced a second transition at higher temperatures with a
corresponding Tm of 69C, which we interpret as the unfolding of
m2m (reference 32).
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Figure 4. Surface representation of pMHC B pockets. The Tyr22 to
Phe22, and Glu24 to Ser24 mutations present in Kbm8 relative to Kb result in
a larger, more accommodating, and neutral B pocket. Residues are represented as CPK models. Peptide atoms are in grayscale. (Yellow) P2 side
chain carbon; (cyan) MHC carbon; (red) MHC oxygen; (orange) waters.
The molecular surfaces of the B pockets are represented with purple dots.
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Discussion
In this paper, we have examined four distinct pMHCs
whose sequence variations are localized to residues located
in the B pocket of the peptide-binding groove. Our goal
was to understand how a compensating mutation in a secondary anchor position of a dominant HSV-1 peptide was
able to restore recognition by Kb-restricted, HSV-1–reactive T cells when in complex with an allelic variant of Kb,
Kbm8. Thus, the second-site revertant Kbm8–H2E, like Kb–
HSV8, elicits activating responses in T cell effector assays,
whereas Kb–H2E and Kbm8–HSV8 do not. We have shown
previously that neither impaired peptide binding nor presentation can explain this differential pMHC recognition
(14). Our current results establish that the loading of HSV8
1452

onto either Kb or Kbm8 results in pMHCs with similar thermal stabilities as measured by CD, whereas the loading of
our designed H2E peptide results in systematically less thermally stable complexes.
Next, we turned to crystallography to elucidate structural details that may provide further insight into our functional observations. The crystal structures of all four pMHCs
were determined and, as expected, the P2 residues of both
HSV8 and H2E are sequestered from solvent in the B
pocket, proximal to the allelic variant residues Tyr22/Phe22
and Glu24/Ser24. To our surprise, comparison of the TCRunliganded structures did not reveal any concerted structural differences localized to the membrane-distal surfaces
of the pMHCs otherwise considered important in TCR
engagement. Furthermore, the small conformational differences of solvent-accessible residues observed in our work
did not appear to correlate with the available TCR recognition data. However, comparison of the manner in which
the P2 secondary anchor residue is engaged in the B pocket
of the pMHCs revealed that the two recognized complexes
have similar packing structures, whereas the B pocket interactions of the ignored complexes are distinct. We will
now turn to considerations of how these results might be
important for the TCR recognition process.
Peptide Anchor Residues and Their Role in the Immune Response. There have been many studies directed at examining TCR–pMHC recognition, many of which have
revolved around the role of solvent-exposed/TCR-contacting peptide residues. Using many different MHC class I
and II systems, it has been shown that TCRs can be extremely sensitive to even conservative mutations at these
solvent-exposed residues (9–11). These results have been
supported by the growing number of TCR–pMHC complex structures available (6–8). It is clear from these structures that a limited number of solvent-exposed peptide residues interact extensively with CDR loops of the TCR,
and that peptide anchor residues and their surrounding
MHC environments are not major recognition determinants. Although anchor residues can unquestionably impact
TCR recognition indirectly by modulating MHC binding
affinity and selection, other mechanisms of action have
been proposed (15, 42–44).
Our current results are similar to a paper we published
several years ago in a class II model (13). We have shown
that for I-Ek/Hb, a minor change in the peptide P6 secondary anchor residue results in both a distinct, nonoverlapping
bulk T cell population as well as a 1,000-fold difference in
specific T cell activation. Structure determination of these
pMHCs revealed minor structural differences in solventexposed atoms and an altered hydrogen-bonding network
in the P6 pocket. Similarly, our Kb/Kbm8 data demonstrate
that perturbations of buried residues can have a significant
impact on T cell repertoire generation, selection, and specificity. Indeed, although functional stability of Kb–Kbm8–HSV8
complexes was indistinguishable as measured by both Abbased (14) and T cell–based assays (29), T cell repertoire selection in the thymus, T cell diversity mobilized in response
to HSV-1 infection, and T cell–mediated resistance to lethal
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parent correlation with T cell recognition profiles (Fig. 5).
In the TCR-recognized Kb–HSV8 complex, SerP2 forms
two distinct hydrogen bonds: one to Glu24 at the base of the
pocket and another to Wat2, which mediates a linkage to
Glu63. In contrast, this same peptide in complex with Kbm8
has an altered hydrogen-bonding pattern and distinct B
pocket chemical environment. Specifically, the Glu24 to
Ser24 bm8 mutation makes the pocket more neutral and
causes Tyr45 to reposition to establish a water-mediated hydrogen bond with SerP2 of HSV8. Additionally, the repositioning of Wat2 allows Glu63 to hydrogen bond with the P2
main chain nitrogen. Although these B pocket alterations
are small, they are clearly significant enough that the Kbm8–
HSV8 complex does not activate Kb–HSV8-reactive T cells.
TCR recognition of Kbm8 presenting the dominant
HSV-1 epitope is regained with the introduction of a compensating peptide mutation at the P2 secondary anchor
position, SerP2 to GluP2. The resulting H2E peptide, in
complex with Kbm8, is able to faithfully mimic the hydrogen-bonding network observed in the Kb–HSV8 complex
(Fig. 5). The GluP2 side chain extends to displace Wat2 and
place its carboxylate group in a position similar to the carboxylate of Glu24 in Kb. This similar positioning allows for
both restoration of the pocket’s negative charge and establishment of a hydrogen-bonding pattern analogous to Glu24
in Kb. However, TCR recognition is again lost when the
H2E peptide is in complex with Kb. GluP2 assumes an alternate conformation, likely due to charge repulsion from
Glu24, causing disruption of hydrogen bonding between
Glu24 and Asn70; this allows Wat2 back into the pocket, and
introduces a new hydrogen bond between its carboxylate
and the P3 main chain nitrogen. This hydrogen bond complements part of its negative charge, likely helping to stabilize the Kb–H2E complex.
Thus, the results of our structural analysis would indicate
that the designed peptide variant H2E is able to successfully
form a similar packing geometry and chemistry of the B
pocket when bound to Kbm8 as is otherwise formed only
when HSV8 is complexed with Kb. In contrast, significant
alterations to the B pocket hydrogen-bonding network are
readily apparent in the other two pMHCs that fail to be
recognized by Kb–HSV8-reactive T cells.
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all the biological consequences of the TCR–pMHC contact. Moreover, this also implies that the self-peptides that
mediate differential positive selection of TCR when presented by either Kb or Kbm8 must themselves participate in
analogous, variable B pocket interactions as does the dominant HSV-1 epitope, providing another level of similarity
between antigenic and positively selecting peptides.
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